Portage Biotech Inc. reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported net loss was USD 5.92 million compared to USD 1.73 million a year ago. Basic loss per share from continuing operations was USD 0.33 compared to USD 0.13 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.26 USD | +8.24% | -12.52% | -85.71% |
Apr. 15 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
Apr. 12 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.71% | 5.14M | |
+1.77% | 42.86B | |
+45.04% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- PRTG Stock
- News Portage Biotech Inc.
- Portage Biotech Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023